Back to Profitus offerings

Butas Pilies g.

Profitus
CrowdSpace is not liable for the content presented in this offering. Check with the information on the official Profitus website and make informed decisions based on your own research.
100 %
  • Status funded
  • Goal 157,500 EUR (€)
  • Raised 157,500 EUR (€)
  • Investors 140
  • Interest rate 6%
  • Loan To Value(LTV) 57%
  • Credit Duration 12 month

Project “Butas Pilies g.“. Project funds will be used for refinancing, the amount collected is EUR 157 500.

The project funds will be used to refinance the previous loan. The owner of the project purchased land plots in Zujunai with previously financed funds, where he developed the infrastructure and sold it. The proceeds from the sale were invested in the acquisition of new plots of land. The project owner acquired land plots in Kalnenai, Vilnius. These plots are going to develop infrastructure and then sell. The proceeds of the sale will cover this loan.

To ensure the interests of investors, a 97.88 square meter, two-storey, fully equipped apartment is pledged in the Old Town of Vilnius, at Pilies str. 19, Vilnius. According to an independent real estate appraiser, the value of the mortgaged real estate is EUR 281,000.

The project owner’s company has been operating in the food flow sector for about 20 years. In addition, the project owner is engaged in the purchase and sale and development of real estate. Having previously received funding on the Profitus platform, he paid interest on time.

Interest by investment amount:
– From EUR 100 to EUR 999 – 6%
– From EUR 1000 to EUR 9 999 – 7%
– From EUR 10 000 – 8%

Important: individual investments are not aggregated.

We plan to raise the amount within 7 days, with the option of extending it to 21 days if we do not raise funds.

crowdfunding report 2023
Get our latest European Crowdfunding Market Report 2023

Our brand new report gives insights into the state of the crowdfunding market in general and goes in-depth regarding funding volumes, backer and fundraiser profiles, regulatory implications, technical challenges and more. Grab your copy, it's FREE!